港股创新药持续强势,多只ETF周涨幅超8%,“上半年最强主线”稳了?
Mei Ri Jing Ji Xin Wen·2025-06-13 08:41

Market Overview - The Shanghai Composite Index briefly surpassed 3400 points but adjusted to close at 3377 points, resulting in a weekly decline of 0.25% [1] - The performance of ETF products varied significantly across different sectors, with Hong Kong innovative drug-related products experiencing substantial gains, potentially becoming the strongest theme for the first half of the year [1] ETF Performance - The S&P Oil & Gas ETF led the weekly gains with a rise of 12.23%, driven by geopolitical tensions in the Middle East, which caused a spike in international oil prices [5] - Eight Hong Kong innovative drug-related ETFs recorded weekly gains exceeding 10%, indicating strong market interest in this sector [5] - Year-to-date, the top-performing ETFs are those related to Hong Kong innovative drugs, with several products showing gains over 60% [5] Declining Sectors - The Wine ETF experienced a significant decline of 5.55% this week, continuing a downward trend that has persisted for five years, with a year-to-date drop exceeding 11% [10] - Other sectors such as food and beverage ETFs also faced declines, with several products reporting weekly drops over 4% [10]